COPD Research Studies

Interested in joining a clinical research trial?

We are currently conducting COPD studies with multiple treatments offered. These studies hope to prove that these treatments are effective at alleviating some of the discomforts that accompany individuals suffering from COPD or emphysema. Medications are provided at absolutely no cost, with no insurance needed. You may also be reimbursed for your time and travel and will receive care from physicians affiliated with the Clinical Research Center of Alabama.

For more information on any of the following COPD or emphysema clinical research studies, please contact Will O’Donnell by calling 205.209.4179 or emailing wodonnell@alabamaallergy.com

Triple Therapy Compared to Single Therapy Inhaler Study

Age 40-80

Airwise

The main purpose of this study is to compare COPD exacerbations (breathing gets worse) in patients who are prescribed Stiolto® Respimat® compared to patients who are prescribed a combination of three approved inhaled COPD medications, called Triple Therapy (inhaled corticosteroid plus long-acting beta agonists combination plus long-acting muscarinic antagonists).

Become a Participant in our COPD studies

If you’re interested in participating in a clinical research study at the Clinical Research Center of Alabama, call 205.209.4100 to speak with an experienced coordinator or fill out the contact form below.